tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
LEXX
Lexaria Bioscience
RESEARCH TOOLSreports
Want to see LEXX full AI Analyst Report?

Lexaria Bioscience (LEXX) Stock News & Sentiment

245 Followers
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
Premium
Company Announcements
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
17d ago
LEXX
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
Premium
Company Announcements
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
25d ago
LEXX
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
Premium
Company Announcements
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
1M ago
LEXX
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
Premium
Company Announcements
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
1M ago
LEXX
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
Premium
Company Announcements
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
1M ago
LEXX
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
Premium
Company Announcements
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
2M ago
LEXX
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
Premium
Company Announcements
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
3M ago
LEXX
More LEXX News >

LEXX News on the Web

Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
TipRanks News
Bullish
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
TipRanks News
Bullish
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
TipRanks News
Bullish
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
TipRanks News
Bullish
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
TipRanks News
Bullish
Lexaria Bioscience to begin new human clinical study in GLP-1
TipRanks News
Bullish
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
TipRanks News
Bullish
Lexaria receives five new patents, including two for diabetes treatment
TipRanks News
Bullish

News Score - Last 7 Days

Positive
LEXX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LEXX’s Media Buzz Sentiment?
2 articles about LEXX were published this week. In an average week, 1.75 articles are published.
    What is LEXX’s weekly average amount of articles?
    In an average week, 1.75 articles about LEXX are published.
      What is LEXX’s News Sentiment?
      100% of articles about LEXX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week